What’s Next in CAR T Cell Therapy with Dr. Michel Sadelain

No video

What’s Next in CAR T Cell Therapy with Dr. Michel Sadelain

Рет қаралды 38,355

Cancer Research Institute

Күн бұрын

Пікірлер: 24

@georgereese2066 3 жыл бұрын

Outstanding

@leoniegray6404 2 жыл бұрын

Thankyou for posting this info . My son has acute lymphoblastic t cell leukaemia .

@geraldpawlish6775 4 жыл бұрын

That was exceptionally well explained.

@rbkuwar 3 жыл бұрын

Great talk .

@222222Myutube 5 жыл бұрын

I am writing my cover letter to join a research group that works in Immunotherapy! Your work is inspiring and bringing hope :)

@penguinlieo4723 4 жыл бұрын

Ahmed El-Molla I will give up if I cannot find a new team to join this year. Very hard due to my age.

@222222Myutube 4 жыл бұрын

@@penguinlieo4723 I have been applying for a lot of time as well, and it's really hard indeed. But I think it's even harder when you start working. So don't give up man. Not now and not later when you are accepted in a good place inshaAllah :)

@parvinakbari8464 4 жыл бұрын

Thank you very much for preparing this great webinar which could help me out to appreciate more precisely. I am very interested in immunotherapy and I also am going to present my project in this significant field. As you have mentioned TME is able to produce molecular and cellular barriers for decreasing CAR T cells’ efficiency and preventing from CAR T cells’ entrance in solid tumors. Many thanks once again.

@CancerResearchInstitute 4 жыл бұрын

Wow, thank you for the feedback, Parvin :)

@arthurv4401 5 жыл бұрын

Great webinair guys!

@Lezgin851 4 жыл бұрын

Dear Colleagues. Thank you for very informative and helpful information. I am agree that this like therapy will be useful in cancer treatment. How I can apply for investigation in the this field. I have some ideas for fighting against cancer.

@chi6168 4 жыл бұрын

Can CAR T-cell therapy be used to treat thalassemia and sickle cell anemia?

@rmd8790 4 жыл бұрын

Have any clinical trials been conducted with CAR-T cells targeting solid tumours such as Osteosarcoma? My son was diagnosed with Osteosarcoma in June 2018, and since then he has had limb salvage surgery & multiple rounds of aggressive pre- and post-surgery chemotherapy. Sadly he has had a few relapses since his treatment finished earlier this year, and his recent PET scan in November 2019 has detected multiple tumours throughout his body, including in his lungs. He is now back on chemotherapy, and we are now resigned to the fact that the chemotherapy is just a short term solution. We have read up on CAR-T cell immunotherapy, which seems to be quite effective, and would be very grateful if you could advise whether this may be an option in treating our son's diagnosis. If not, are you aware of any other treatments available? Thanking you very much in advance.

@CancerResearchInstitute 4 жыл бұрын

Hi Ritesh. You can find current immunotherapy treatment options and clinical trials on our website here: www.cancerresearch.org/immunotherapy/cancer-types/childhood-cancer www.cancerresearch.org/immunotherapy/cancer-types/sarcoma

@theHerathrig 4 жыл бұрын

When can we expect car t for liver, pancreas, stomach and colon cancer?

@CancerResearchInstitute 4 жыл бұрын

There are adoptive cell therapies in clinical trials for all those cancers. Learn more: liver cancer - www.cancerresearch.org/immunotherapy/cancer-types/liver-cancer pancreatic cancer - www.cancerresearch.org/immunotherapy/cancer-types/pancreatic-cancer stomach cancer - www.cancerresearch.org/immunotherapy/cancer-types/stomach-cancer colorectal cancer - www.cancerresearch.org/immunotherapy/cancer-types/colorectal-cancer

@zhexu1727 3 жыл бұрын

many ongoing trials, but its very hard to do car t on solid tumor due to many microenvironment limitations.

@em34ev3r 2 жыл бұрын

@@zhexu1727 The answer to the micoenvironment situation is to destroy it. High dose IV vitamin C and even a healthy diet largley consisting of vegetables, does a great job at unraveling the microenvironment. Chemotherapy only kills the tumors and by doing that, it creates a debris and collection of dead cells which adds onto the cancer microenvironment, highly acidic and anerobic area.